Multiflorin A
Multiflorin A is an orally active active ingredient of traditional herbal laxative, Pruni semen. Multiflorin A inhibits aromatase enzyme activity with an IC50 of 15.5 μM. Multiflorin A also inhibits quinone reductase 2 (QR2) and COX-2 enzyme. Multiflorin A has purgative activity and reduces postprandial blood glucose in mice. Multiflorin A modulates intestinal glucose transporters, tight junction proteins, and aquaporins, reshapes gut microbiota, and alters faecal metabolites. Multiflorin A can be used for the research of constipation and diabetes.
For research use only. We do not sell to patients.
- CAS No.: 1350028-90-8
- Formula: C29H32O16
- Molecular Weight:636.55
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
IC50 & Target
[1]|
Aromatase 15.5 μM (IC50) |
COX-2 |
In Vitro
Multiflorin A potently inhibits aromatase enzyme activity with an IC50 of 15.5 μM[2].
Multiflorin A (11.5 μg/mL) inhibits QR2 enzyme activity by 39%[2].
Multiflorin A (10 μg/mL) stimulates COX-1 enzyme activity by 29% and inhibits COX-2 enzyme activity by 16%[2].
Multiflorin A (20 μg/mL; 6 h) does not inhibit TNF-α-induced NF-κB activity in human embryonic kidney 293 cells at a concentration of 20 μg/mL[2].
Multiflorin A (20 μg/mL) exhibits no significant cytotoxicity toward Hepa1c1c7 or MCF-7 cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
Multiflorin A (10-20 mg/kg; i.g.; single dose) effectively reverses Loperamide hydrochloride (HY-B0418A)-induced constipation in male ICR mice, significantly reducing first stool time and increasing faecal water content[1].
Multiflorin A (10 mg/kg; i.g.; single dose) inhibits postprandial blood glucose elevation in male ICR mice, with effects persisting for at least 6 h after administration[1].
Multiflorin A (10-20 mg/kg; i.g.; daily; 3 days) modulates intestinal glucose transporters, tight junction proteins, and aquaporins, reshapes gut microbiota, and alters faecal metabolites in male ICR mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ICR (male, 24-26 g)[1]
-
Dosage:20 mg/kg; 40 mg/kg
-
Administration:p.o.; single dose
-
Result:Induced watery diarrhoea in 62% of mice, significantly decreased the time to first red stool, and significantly increased faecal water content compared to controls at 20 mg/kg.
Induced watery diarrhoea in 100% of mice, significantly decreased the time to first red stool, and significantly increased faecal water content compared to controls at 40 mg/kg.
Caused noticeable watery diarrhoea and intestinal distension in fed mice, while fasted mice showed no watery diarrhoea.
-
Animal Model:ICR (male, 24-26 g, loperamide-induced constipation)[1]
-
Dosage:10 mg/kg; 20 mg/kg
-
Administration:p.o.; single dose
-
Result:Significantly decreased the time to first red stool and significantly increased faecal water content compared to the loperamide-induced constipation model group at 10 mg/kg.
Significantly decreased the time to first red stool and significantly increased faecal water content compared to the loperamide-induced constipation model group at 20 mg/kg.
Chemical Information
-
CAS No. 1350028-90-8
-
Appearance Solid
-
Molecular Weight 636.55
-
Formula C29H32O16
-
Color Off-white to yellow
-
SMILES
O=C1C2=C(O)C=C(O)C=C2OC(C3=CC=C(C=C3)O)=C1O[C@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)C)O[C@@H]5O[C@@H]([C@H]([C@@H]([C@H]5O)O)O)COC(C)=O)O)O
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Research Protocol for Microbiome Analysis
Microbiome analysis characterizes microbial communities in biological or environmental samples by measuring community composition, diversity, taxonomic structure, functional potential, and associations with host or environmental phenotypes. 16S rRNA gene amplicon sequencing is commonly used for bacterial and archaeal taxonomic profiling, while shotgun metagenomics provides higher taxonomic resolution and direct functional information, including microbial genes, pathways, viruses, fungi, and antimicrobial-resistance genes when sequencing depth and host-DNA contamination are adequately controlled. Microbiome results are strongly affected by sample collection, storage, DNA extraction, contamination, sequencing method, reference database, and bioinformatic pipeline; therefore, standardized protocols, negative controls, mock communities, and transparent analysis workflows are required. Unresolved issues include low-biomass contamination, compositional-data bias, inconsistent species-level c
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
Purity & Documentation
-
Data Sheet (298 KB)
-
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)